0001193125-11-101918.txt : 20110419 0001193125-11-101918.hdr.sgml : 20110419 20110419122534 ACCESSION NUMBER: 0001193125-11-101918 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110418 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20110419 DATE AS OF CHANGE: 20110419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 11767379 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): April 18, 2011

 

 

ELI LILLY AND COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Indiana   001-06351   35-0470950

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

Lilly Corporate Center

Indianapolis, Indiana

     46285

(Address of Principal

Executive Offices)

     (Zip Code)

Registrant’s telephone number, including area code: (317) 276-2000

No Change

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders

We held our annual meeting of shareholders on April 18, 2011. The following is a summary of the matters voted on at the meeting:

 

  a) The four nominees for director were elected to serve three-year terms ending in 2014, as follows:

 

Nominee

  

For

  

Against

  

Abstain

  

Broker

Nonvote

Michael L. Eskew

   858,277,579   20,653,067   2,630,737   117,759,723

Alfred G. Gilman

   867,419,016   11,496,682   2,645,685   117,759,723

Karen N. Horn

   819,355,507   59,450,060   2,755,816   117,759,723

John C. Lechleiter

   857,368,007   21,747,912   2,445,464   117,759,723

 

  b) The appointment of Ernst & Young LLP as our principal independent auditor was ratified by the following shareholder vote:

 

For:

      986,619,977      

Against:

      10,370,964      

Abstain:                           

      2,330,165      

 

  c) By the following vote, the shareholders approved an advisory vote on 2010 compensation paid to named executive officers:

 

For:

      771,097,867      

Against:

      102,649,442      

Abstain:

      7,814,074      

Broker Nonvote:            

      117,759,723      

 

  d) By the following vote, the shareholders voted, on an advisory basis, to hold future advisory votes on executive compensation on an annual basis:

 

Annually:

      735,421,559      

Every 2 years:

      7,330,463      

Every 3 years:

      134,001,483      

Abstain:

      4,807,878      

Broker Nonvote:            

      117,759,723      

 

2

  e) By the following vote, the shareholders did not approve the proposal (which required the vote of 80 percent of outstanding shares) to amend the company’s articles of incorporation to provide for annual election of directors:

 

For:

      848,841,946      

Against:

      145,932,392      

Abstain:                           

      4,546,768      

 

  f) By the following vote, the shareholders did not approve the proposal (which required the vote of 80 percent of outstanding shares) to amend the company’s articles of incorporation to eliminate all supermajority voting requirements:

 

For:

      840,513,773      

Against:

      151,928,189      

Abstain:                           

      6,879,144      

 

  g) By the following vote, the shareholders approved the Eli Lilly and Company Executive Officer Incentive Plan:

 

For:

      803,999,103      

Against:

      70,125,135      

Abstain:

      7,437,145      

Broker Nonvote:            

      117,759,723      

As of the record date of the meeting, 1,157,664,779 shares of common stock were issued and outstanding.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ELI LILLY AND COMPANY

(Registrant)

By:   /s/ James B. Lootens
Name:   James B. Lootens
Title:   Corporate Secretary
Dated: April 19, 2011

 

3